At a glance
- Originator Wyeth
- Class Aminobenzoic acids; Antihyperlipidaemics
- Mechanism of Action Sterol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia
Most Recent Events
- 15 Feb 1995 Discontinued-II for Hyperlipidaemia in USA (unspecified route)